ScreenerHero

GTIIGreen Thumb Industries Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · gtigrows.com
10.25CAD-0.19%Mkt Cap: 1.63B $P/E: 13.49

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The com…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$62.66BUSDP/E 24.3
TAK
Takeda Pharmaceutical Company Limited
$60.33BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.72BUSDP/E 66.8
HLN
Haleon plc
$41.16BUSDP/E 19.5
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.6
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.6
UTHR
United Therapeutics Corporation
$21.22BUSDP/E 17.7
VTRS
Viatris, Inc.
$19.47BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.80BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.63BUSDP/E 21.0
IPN
Ipsen S.A.
$13.27BUSDP/E 24.0
ELAN
Elanco Animal Health Incorporated
$11.20BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.33BUSDP/E 30.2
KRK
Krka, d. d.
$8.66BUSDP/E 18.8
ALKS
Alkermes plc
$7.41BUSDP/E 116.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.02BUSDP/E 42.0
HIMS
Hims & Hers Health, Inc.
$6.85BUSD
LNTH
Lantheus Holdings, Inc.
$6.55BUSDP/E 24.0
KNSA
Kiniksa Pharmaceuticals International, plc
$6.10BUSDP/E 78.9
LQDA
Liquidia Corporation
$5.95BUSDP/E 47.5

Key Statistics

Company
Market Cap1.63B $
Enterprise Value1.83B $
Revenue (TTM)880.74M $
Gross Profit418.67M $
Net Income (TTM)83.13M $
Revenue/Share3.850 USD
Last Price10.25 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.9K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA39342L1085
Valuation
P/E (Trailing)13.49
P/E (Forward)21.75
PEG1.77
EV/EBITDA9.34
EV/Revenue2.07
P/S1.84
P/B0.87
EPS (TTM)0.76
EPS (Forward)0.47
52W Range
7.40041% of range14.39
52W High14.39 CAD
52W Low7.400 CAD
Profitability
Gross Margin48.91%
Oper. Margin6.51%
EBITDA Margin22.20%
Profit Margin9.71%
ROE5.99%
ROA4.09%
Growth
Revenue Growth4.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF214.78M $
CapEx (TTM)59.04M $
FCF Margin12.53%
FCF Yield6.76%
Net Debt201.45M $
Net Debt/EBITDA1.03
Balance Sheet
Debt/Equity0.27
Current Ratio2.85
Quick Ratio1.54
Book Value/Sh11.77 CAD
Cash/Share1.297 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:368
Split DateJun 13, 2018
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.16 CAD
Upside (mean)+106.4%
Target Range17.92 CAD – 24.97 CAD
CAD17.92+106.4% to meanCAD24.97
# Analysts5
Ownership
Shares Out.197.36M
Float191.02M
Insiders1.88%
Institutions8.13%
Short Interest
Short Ratio2.2d
Short % Float0.15%
Short % Out.0.13%
Shares Short293.47K
Short (prev mo.)163.31K
Technical
SMA 5010.18 (+0.7%)
SMA 20010.14 (+1.1%)
Beta0.93
S&P 52W Chg14.29%
Avg Vol (30d)116.10K
Avg Vol (10d)107.02K
Technical Indicators
RSI (14)52.8
MACD0.0084
MACD Signal-0.0795
MACD Hist.+0.0879
BB Upper10.52 CAD
BB Middle9.931 CAD
BB Lower9.340 CAD
BB Width11.89%
ATR (14)0.3892 CAD
Vol Ratio (20d)0.22x